BenQ Medical Technology
BenQ Medical Technology Corporation engages in the manufacture, installation, maintenance, and repair of medical device and various medical equipment in Taiwan, Mainland China, India, and internationally. It operates through R&D and Manufacturing, and Medical Services segments. The company offers wholesale and retail sales of medical device, medical equipment, pharmaceutical, health food, and the… Read more
BenQ Medical Technology (4116) - Total Assets
Latest total assets as of June 2025: NT$5.27 Billion TWD
Based on the latest financial reports, BenQ Medical Technology (4116) holds total assets worth NT$5.27 Billion TWD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
BenQ Medical Technology - Total Assets Trend (2017–2024)
This chart illustrates how BenQ Medical Technology’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
BenQ Medical Technology - Asset Composition Analysis
Current Asset Composition (December 2024)
BenQ Medical Technology's total assets of NT$5.27 Billion consist of 58.8% current assets and 41.3% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 16.4% |
| Accounts Receivable | NT$905.41 Million | 17.2% |
| Inventory | NT$783.12 Million | 14.9% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$0.00 | 0.0% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how BenQ Medical Technology's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BenQ Medical Technology's current assets represent 58.8% of total assets in 2024, an increase from 41.1% in 2017.
- Cash Position: Cash and equivalents constituted 16.4% of total assets in 2024, up from 14.6% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 17.2% of total assets.
BenQ Medical Technology Competitors by Total Assets
Key competitors of BenQ Medical Technology based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
BenQ Medical Technology - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - BenQ Medical Technology generates 0.90x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, BenQ Medical Technology generates $ 1.99 in net profit.
BenQ Medical Technology - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.58 | 1.83 | 1.73 |
| Quick Ratio | 1.14 | 1.44 | 1.26 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$1.15 Billion | NT$ 1.17 Billion | NT$ 303.41 Million |
BenQ Medical Technology - Advanced Valuation Insights
This section examines the relationship between BenQ Medical Technology's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.72 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 11.9% |
| Total Assets | NT$5.27 Billion |
| Market Capitalization | $25.45 Million USD |
Valuation Analysis
Below Book Valuation: The market values BenQ Medical Technology's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: BenQ Medical Technology's assets grew by 11.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for BenQ Medical Technology (2017–2024)
The table below shows the annual total assets of BenQ Medical Technology from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | NT$5.27 Billion | +11.92% |
| 2023-12-31 | NT$4.71 Billion | +38.67% |
| 2022-12-31 | NT$3.40 Billion | +73.79% |
| 2021-12-31 | NT$1.96 Billion | +8.93% |
| 2020-12-31 | NT$1.79 Billion | +6.14% |
| 2019-12-31 | NT$1.69 Billion | +0.56% |
| 2018-12-31 | NT$1.68 Billion | +8.98% |
| 2017-12-31 | NT$1.54 Billion | -- |